Cancer IQ
Chicago, US · Delaware corporation · 3 known investors
Precision cancer prevention platform that stratifies patient risk and enables earlier detection through risk scoring and monitoring.
Founders & leadership
OO
Olufeyikemi Olopade AyodeleFounder
HL
Haibo LuNamed on SEC filing
CB
Christopher BunNamed on SEC filing
JD
Jordan DolinNamed on SEC filing
EW
Evan WoodNamed on SEC filing
OO
Olufunmilayo OlapadeNamed on SEC filing
PB
Paul BurtonNamed on SEC filing
Board
MB
JK
Joel KrikstonBoard director
CE
Carladenise EdwardsBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$19.9M disclosed across 3 rounds · 2020–2023
▶$4.3MraisedMay 2026 · 9 investors · Other TechnologyRule 506(b)
▶$4.3MraisedMay 2026 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Carladenise EdwardsDirector
- Mark BakkenDirector
- Haibo LuExecutive Officer, Director
- Joel KrikstonDirector
- Olufeyikemi Olopade AyodeleExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $4.3M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14MraisedApr 2022 · 6 investors · Other TechnologyRule 506(b)
▶$14MraisedApr 2022 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark BakkenDirector
- Haibo LuExecutive Officer, Director
- Andrea MetkusDirector
- Olufeyikemi Olopade AyodeleExecutive Officer, Director
- Joel KrikstonDirector
- Offering amount
- $14M
- Amount sold
- $14M
- Sales commissions
- $396K
- Placement agents
- B. C. Ziegler and Company
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedApr 2020 · 5 investors · Other TechnologyRule 506(b)
▶$1.6MraisedApr 2020 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher BunExecutive Officer
- Jordan DolinDirector
- Haibo LuExecutive Officer
- Evan WoodDirector
- Olufunmilayo OlapadeDirector
- Mark BakkenDirector
- Olufeyikemi Olopade AyodeleExecutive Officer, Director
- Paul BurtonExecutive Officer
- Offering amount
- $2.6M
- Amount sold
- $1.6M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Cancer IQ do?
- Precision cancer prevention platform that stratifies patient risk and enables earlier detection through risk scoring and monitoring.
- Who founded Cancer IQ?
- Cancer IQ was founded by Olufeyikemi Olopade Ayodele.
- Who are Cancer IQ's investors?
- Cancer IQ's investors include HealthX Ventures, Merck Global Health Innovation Fund, OSF Ventures.
- How much funding has Cancer IQ raised?
- Cancer IQ has disclosed $19.9M raised across 3 rounds.
- Where is Cancer IQ headquartered?
- Cancer IQ is headquartered in Chicago, US.